Somaxon Pharmaceuticals, Inc (NASDAQ:SOMX) Somaxon Pharmaceuticals, Inc. (Somaxon) is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of branded products and late-stage product candidates. Somaxon Pharmaceuticals, Inc witnessed volume of 1.33 million shares during last trade however it holds an average trading capacity of 162,749 shares. SOMX last trade opened at $0.46 reached intraday low of $0.45 and went -4.00% down to close at $0.480.
SOMX has intra-day market capitalization $23.03 million and an enterprise value at $3.27 million. Trailing twelve months price to sales ratio of the stock was 1.70 while price to book ratio in most recent quarter was 1.46. In profitability ratios, operating profit margin in past twelve months appeared at -466.34%.
The company made a return on asset of -83.53% in past twelve months and return on equity of -218.76% for similar period. In the period of trailing 12 months it generated revenue amounted to $13.58 million gaining $0.31 revenue per share.
According to preceding quarter balance sheet results, the company had $34.76 million cash in hand making cash per share at 0.72. The total of $15.00 million debt was there putting a total debt to equity ratio 95.23. Moreover its current ratio according to same quarter results was 1.55 and book value per share was 0.33.
Looking at the trading information, the stock price history displayed that its S&P500 52 Week Change illustrated -1.39% where the stock current price exhibited down beat from its 50 day moving average price of $0.78 and remained below from its 200 Day Moving Average price of $1.21.
SOMX holds 47.98 million outstanding shares with 37.98 million floating shares where insider possessed 7.33% and institutions kept 55.90%.
No comments:
Post a Comment